Table 2:
Relationship Between OxyContin Misuse and Changes in Heroin Death Rates
| Outcome: | Heroin Deaths per 100,000 |
|||||
|---|---|---|---|---|---|---|
| (1) | (2) | (3) | (4) | (5) | (6) | |
| A. Total Heroin Deaths per 100,000 | ||||||
| Initial OxyContin (3 Year Effect) | 2.212** (1.012) | 2.804*** (1.041) | 2.523** (1.065) | 3.581*** (1.074) | 1.420*** (0.616) | 1.591*** (0.608) |
| Initial Pain Reliever (3 Year Effect) | −0.495** (0.241) | −0.210* (0.114) | ||||
| Mean of Dep. Variable (2008–09): | 1.060 | |||||
| B. Heroin-Only Deaths per 100,000 (T40.1 but not also T40.2-T40.4) | ||||||
| Initial OxyContin (3 Year Effect) | 1.497 (0.911) | 2.068** (0.879) | 1.849** (0.920) | 2.694*** (0.894) | 1.518** (0.647) | 1.727*** (0.649) |
| Initial Pain Reliever (3 Year Effect) | −0.392* (0.198) | −0.194* (0.116) | ||||
| Mean of Dep. Variable (2008–09): | 0.876 | |||||
| State and Time-Varying Covariates | No | Yes | Yes | Yes | Yes | Yes |
| Policy Variables | No | No | Yes | Yes | Yes | Yes |
| Estimator | OLS | OLS | OLS | OLS | Poisson | Poisson |
Notes: Standard errors in parentheses adjusted for clustering at the state-level. State fixed effects and year fixed effects included in all specifications. Each model also includes a linear trend interacted with initial nonmedical OxyContin misuse as well as a post-2011 indicator interacted with initial nonmedical OxyContin misuse. Finally, a separate post-2011 linear trend interacted with initial nonmedical OxyContin misuse is also included. We report the 3 year post-2011 effect of the initial OxyContin variable. Regressions are weighted by population. Years 2008–2013 are used.
Significant at the 1% level
Significant at the 5% level
Significant at the 10% level.